[go: up one dir, main page]

WO2005038008A1 - A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria - Google Patents

A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria Download PDF

Info

Publication number
WO2005038008A1
WO2005038008A1 PCT/KR2003/002156 KR0302156W WO2005038008A1 WO 2005038008 A1 WO2005038008 A1 WO 2005038008A1 KR 0302156 W KR0302156 W KR 0302156W WO 2005038008 A1 WO2005038008 A1 WO 2005038008A1
Authority
WO
WIPO (PCT)
Prior art keywords
soybean
lactic acid
korean
acid bacteria
bifidobacterium breve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2003/002156
Other languages
French (fr)
Inventor
Seng-Bae Han
Yeong-Hye Yun
Young-Hee Kim
Sook-Hee Park
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BARUMIN Co Ltd
Original Assignee
BARUMIN Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BARUMIN Co Ltd filed Critical BARUMIN Co Ltd
Priority to PCT/KR2003/002156 priority Critical patent/WO2005038008A1/en
Priority to AU2003273069A priority patent/AU2003273069A1/en
Publication of WO2005038008A1 publication Critical patent/WO2005038008A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/005Amino acids other than alpha- or beta amino acids, e.g. gamma amino acids
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L11/00Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
    • A23L11/50Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein

Definitions

  • the present invention relates to a method for preparing a fermentation product of soybean having enriched ⁇ -aminobutyric acid and phytoestrogens using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria. More specifically, it relates to a method for preparing a fermentation product of soybean, said method comprising steps of soaking soybean in water for 4 ⁇ 6 hours, admixing said soaked soybean with water in a ratio of 1 :2 to 1 :8(W/V), grinding them to obtain the ground materials of soybean, heating them to a temperature of 60 °C ⁇ 75 °C and allowing them to cool, and then fermenting them for 12 ⁇ 48 hours, when performing of a soybean fermentation using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria; and a method for preparing a freeze- dried fermentation product of soybean comprising the steps of adding ascorbic acid to said ground materials of soybean in concentration of 0.025 ⁇ 0.2%, heating and allowing them
  • a method for preparing a fermentation product of soybean in which lactic acid bacteria was fermented comprising the steps of grinding germinated soybean to obtain the ground materials of soybean, adding 0.05% of ascorbic acid thereto, inoculating 1% of the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria(1.5 ⁇ 2.0 X 10 2 ⁇ l) into them and then fermenting them for 12 ⁇ 48 hours at 37 °C .
  • the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria has a property which can improve intestinal climate and also inhibit productivity of harmful enzymes by intestinal bacteria.
  • Bifidobacterium appears on day 3 - 4 after his birth, and become the most dominant bacteria on day 5 after his birth.
  • anaerobic bacteria and Bifidobacterium are dominant, while other lactic acid bacteria, Lactobacillus, etc. are much less.
  • bacterial type of the intestinal bacteria becomes aged and then the influence of dominant Bifidobacterium becomes weak, so the influence of Lactobacillus becomes stronger than that of the Bifidobacterium.
  • Lactobacillus are classified into two groups, one group which does homofermentation and the other group which does heterofermentation, respectively while Bifidobacterium does heterofermentation only.
  • Important characteristics of Bifidobacterium breve K-110 of Korean-type lactic acid bacteria are in that it has an therapeutic effect of treating colon cancer, bladder cancer and ascites cancer (J. Microbiol. Biotechnol.
  • lactic acid bacteria examples include inhibition of the growth of harmful bacteria, alleviation of lactose intolerance, reduction of serum cholesterol, anti-cancer action, immunological action, relief of diarrhoea and constipation, vitamin synthesis, etc.
  • Bifidobacteria begin to appear from about day 3 - 4 after one's birth, then grow to be the most dominant bacteria on about day 5 and existing E.coli or other lactic acid bacteria, Lactobacillus, Streptococcus, etc. decrease to one hundredth.
  • the prior art is a generalized method comprising the steps of inoculating lactic acid bacteria into milk and adding powdered skim milk thereto to proliferate lactic acid bacteria so as to thereby prepare lactic acid beverage.
  • Examples of patents for producing lactic acid beverage or lactic acid using cereals include a vegetable and herbal materials-derived lactic acid fermentation beverage (Korean Patent Publication Laid-Open No.
  • these methods comprise steps of mixing milk, or adding saccharides such as glucose, which is considerably different from the present method, and bacterial strain used therein is also different from the present invention using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria.
  • the object of the present invention is to provide a method for preparing a fermentation product of soybean by using Korean-type lactic acid bacteria, said method comprising the steps of soaking soybean in water for 4 ⁇ 6 hours, adding water to said soaked soybean in a predetermined ratio, grinding them to obtain the ground materials of soybean, heating and allowing them to cool, inoculating said Bifidobacterium breve K-110 into them, and then fermenting them, when performing of a soybean fermentation using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria.
  • Another object of the present invention is to provide a method for preparing a fermentation product of soybean comprising the steps of adding ascorbic acid to the ground materials of soybean in concentration of 0.025 ⁇ 0.2% and fermenting them to thereby promote the growth of the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria, when performing of a soybean fermentation using the Bifidobacterium breve K- 110 of Korean-type lactic acid bacteria.
  • a further object of the present invention is to provide a method for preparing a powdered fermentation product of soybean having viable lactic acid bacteria, comprising the step of freeze-drying a fermentation product of soybean obtained by inoculating the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria into the ground materials of soybean and fermenting them for 12 ⁇ 48 hours.
  • a further object of the present invention is to provide a method for preparing a fermentation product of germinated soybean, comprising the steps of adding ascorbic acid to ground materials of the germinated soybean and fermenting them with the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria.
  • a further object of the present invention is to provide a method for enhancing content of ⁇ -aminobutyric acid, one of the physiologically active substance and phytoestrogens comprising step of fermenting soybean and germinated soybean using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria.
  • Example 1 Determination of the ratio of water in performing of soybean fermentation using Korean-type lactic acid bacteria
  • Commercially available soybean was soaked in water for 4 ⁇ 6 hours and water was drained.
  • Said soaked soybean was mixed with water in a ratio of 1 :2(W/V), 1 :4(W/V) 5 1:6(W/V) and 1:8(W/N), respectively. They were finely ground with a mixer or colloidal mill for 5 — 10 minutes to prepare ground materials of soybean.
  • Said materials were heated and boiled in a double pot or heating vessel for further 5 minutes from when it reached a maximum temperature as shown in Table 1. The maximum temperature showed 60 ⁇ 75 ° C although it was slightly different with a ratio of water.
  • Example 2 Determination of the addition amount of ascorbic acid in performing of soybean fermentation using Korean-type lactic acid bacteria
  • Water-soaked soybean was mixed with water in a ratio of 1:4(W/N) and then finely ground with a mixer or colloidal mill for 5 to 10 minutes to prepare ground materials. Said materials were heated and boiled in a double-pot or heating vessel for further 5 minutes from when it reached a maximum temperature of 75 "Cand then allowed to cool. Thereafter, to said materials was inoculated 1% of Bifidobacterium breve K-l 10 of Korean-type lactic acid bacteria (grown on TS medium for 24 hours). At that time, to examine the effect of ascorbic acid, there was added ascorbic acid with concentrations of 0%, 0.025%, 0.05%, 0.1% and 0.2%, respectively, prior to heating of said ground materials.
  • the number of Bifidobacteria After fermentation, the number of Bifidobacteria has showed 4.40 X 10 9 for the group to which 0% of ascorbic acid was added, 2.02 X 10 12 for the group to which 0.025% of ascorbic acid was added, 9.21 X 10 for the group to which 0.05% of ascorbic acid was added, 2.34 X 10 8 for the group to which 0.1% of ascorbic acid was added and 1.01 X 10 8 for the group to which 0.2% of ascorbic acid was added, respectively.
  • the number of Bifidobacteria increased until addition amount of ascorbic acid increased by 0.05%, while at concentration of ascorbic acid after 0.05% the number of Bifidobacteria rather showed a tendency to decrease. Thus, a suitable addition concentration of ascorbic acid was 0.05% at which the number of Bifidobacteria was maximum.
  • Example 3 Determination of fermentation period Water-soaked soybean was mixed with water in a ratio of 1:4(W/N) and then finely ground with a mixer or colloidal mill for 5 ⁇ 10 minutes to prepare ground materials of soybean. 0.05% of ascorbic acid was added thereto, heated and boiled in a double pot or heating vessel for further 5 minutes from when it reached a maximum temperature of 75 ° C and then allowed to cool. Thereafter, to said materials was inoculated 1% of Bifidobacterium breve K-110 of Korean-type lactic acid bacteria and they were fermented at 37 ° C for 0, 2, 12, 24, 36 and 48 hours to obtain fermentation product of soybean.
  • Example 4 Number of lactic acid bacteria in freeze-drying fermentation product of soybean.
  • bacterial number should be 10 8 /g, while a fermentation product of soybean according to the present invention has 7.79 X 10 12 /g which is much larger than 10 8 /g, thus being capable of using as preparations of lactic acid bacteria.
  • Example 5 Preparation of fermentation product of the Korean-type lactic acid bacteria using germinated soybean
  • Water- soaked soybean for 4 h was germinated at a temperature of 25 ⁇ 30 ° C for 0, 12, 24 and 36 hours, respectively.
  • Said germinated soybean was mixed with water in a ratio of 1:4(W/N) and then finely ground with a mixer or colloidal mill for 5 ⁇ 10 minutes to prepare ground materials of soybean.
  • 0.05% of ascorbic acid was added thereto, heated and boiled in a double pot or heating vessel for further 5 minutes from when it reached a maximum temperature of 75 ° C and then allowed to cool.
  • the 1 number of lactic acid bacteria was 7.07 X 10 for the case of using 24 h-germinated soybean and 1.00 X 10 12 for the case of using 36 h-germinated soybean, respectively, with resulting in decrease of bacterial number by using soybean having a long germination period.
  • germinated soybean it is preferred to use less than 12 h- germinated soybean.
  • Example 6 Content of ⁇ -aminobutyric acid in a fermentation product of soybean using Korean-type lactic acid bacteria
  • ⁇ -aminobutyric acid The content of ⁇ -aminobutyric acid was 89.66 ⁇ 5.97 mg% for 12 h-germinated soybean, but it was 133.24 ⁇ 13.05 mg% for fermenting of 12 h-germinated soybean by using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria, with an increase of about 1.5 times, compared to before fermenting. Thus, it was believed that the Bifidobacterium breve K-110 also had a function of synthesizing ⁇ -aminobutyric acid.
  • ⁇ -aminobutyric acid (GAB A) is one of the neurotransmitters present in cerebrum, etc.
  • ⁇ - aminobutyric acid which is one of the neurotransmitters present in cerebrum, is used as preparations for intravenous injection for improving cerebral blood flow and enhancing cerebral metabolism in cerebral apoplexy, brain trauma and cerebral arterial sequela, and is commercially available as oral preparations in the form of tablet containing 5 ⁇ 10 mg of ⁇ -aminobutyric acid in Japan (Journal of the Japanese Society for Food Science and Technology 46, 323 (1999)).
  • Example 7 Increase in content of isoflavone, phvtoestrogen of soybean fermentation product by using the Korean-type lactic acid bacteria
  • diadzin, glycitin and genistin had been converted to diadzein, glycitein and genistein.
  • isoflavonoids diadzin, glycitin and genistin which are present in soybean don't have effects like phytoestrogens by themselves, but it was reported that diadzein, glycitein and genistein in the form of aglycon in which sugar residues bound to diadzin, glycitin and genistin were removed, have function as phytoestrogens.
  • flavonoids such as diadzin, glycitin and genistin
  • flavonoids having no activity of phytoestrogens prior to fermenting were converted to the form of flavonoids(such as diadzein, glycitein and genistein) having strong activity of phytoestrogens, when fermenting of soybean using lactic acid bacteria.
  • phytoestrogens diadzein, glycitein and genistein have an action to increase a metabolism of carcinogenic substances in cell cultivation experiment, it was reported that they have the effects to prevent breast cancer and prostate cancer and also various kinds of cancers such as gastric cancer, colon cancer, etc. (The Korean Society for the Research of Soybean, Academic Publication 2001), and serve to reduce a risk of cardiovascular diseases and cancers (The Food Industry, Nov. 1998). They say that these phytoestrogens diadzein, glycitein and genistein have an anti- oxidative effect, and among them an anti-oxidative effect of glycitein is greatest (The Korean Society for the Research of Soybean, 14:91 (1997)).
  • the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria capable of enhancing the contents of phytoestrogens diadzein, glycitein and genistein, can be used as a new phytoestrogens-enriched food material or a functional food material.
  • the present invention can provide a lactic acid bacteria-fermentation product of soybean using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria.
  • the fermentation products of soybean and germinated soybean containing more than 10 8 of the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria obtained according to the present invention can be used as preparations of lactic acid bacteria, as well as materials for various functional foods such as materials for health food and materials for eating uncooked food and specified raw food due to high contents of the ⁇ - aminobutyric acid, one of the physiologically active substances and the diadzein, glycitein and genistein functioning as phytoestrogens.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Agronomy & Crop Science (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention relates to a method for preparing a fermentation product of soybean having an enhanced content of #-aminobutyric acid and phytoestrogens by using the Bifidobacterium breve K-110, said method comprising the steps of soaking soybean in water, admixing said soaked soybean with water in a predetermined ratio, grinding them to obtain the ground materials, heating and allowing them to cool, and then fermenting them, when performing of a soybean fermentation using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria. Thus, there is provided a method by characterized in that a fermentation product of soybean having a large number of lactic acid bacteria and also an enhanced content of #-aminobutyric acid and phytoestrogens can be obtained by the above-mentioned fermentation process.

Description

A METHOD FOR PREPARING A FERMENTATION PRODUCT OF SOYBEAN H AVING ENRICHED γ-AMINOBUTYRIC ACID AND PHYTOESTROGENS USING THE BIFIDOBACTERIUM BREVE K-110 OF KOREAN-TYPE LACTIC ACID BACTERIA
Technical Field The present invention relates to a method for preparing a fermentation product of soybean having enriched γ-aminobutyric acid and phytoestrogens using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria. More specifically, it relates to a method for preparing a fermentation product of soybean, said method comprising steps of soaking soybean in water for 4 ~ 6 hours, admixing said soaked soybean with water in a ratio of 1 :2 to 1 :8(W/V), grinding them to obtain the ground materials of soybean, heating them to a temperature of 60 °C ~ 75 °C and allowing them to cool, and then fermenting them for 12 ~ 48 hours, when performing of a soybean fermentation using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria; and a method for preparing a freeze- dried fermentation product of soybean comprising the steps of adding ascorbic acid to said ground materials of soybean in concentration of 0.025 ~ 0.2%, heating and allowing them to cool, inoculating the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria into them, fermenting them for 12 ~ 48 hours and freeze-drying them. Further, it also relates to a method for preparing a fermentation product of soybean in which lactic acid bacteria was fermented, comprising the steps of grinding germinated soybean to obtain the ground materials of soybean, adding 0.05% of ascorbic acid thereto, inoculating 1% of the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria(1.5 ~ 2.0 X 102 \\l) into them and then fermenting them for 12 ~ 48 hours at 37 °C .
Background Art The Bifidobacterium breve K-110 of Korean-type lactic acid bacteria has a property which can improve intestinal climate and also inhibit productivity of harmful enzymes by intestinal bacteria. Referring to a change of intestinal bacteria with age of man, Bifidobacterium appears on day 3 - 4 after his birth, and become the most dominant bacteria on day 5 after his birth. Also, upon completing of weaning period, anaerobic bacteria and Bifidobacterium are dominant, while other lactic acid bacteria, Lactobacillus, etc. are much less. When getting older, bacterial type of the intestinal bacteria becomes aged and then the influence of dominant Bifidobacterium becomes weak, so the influence of Lactobacillus becomes stronger than that of the Bifidobacterium. Thus, as man is getting old, taking of Bifidobacterium will be able to make up an intestinal flora similar to that of infancy or adolescence-manhood. A difference between Lactobacillus and Bifidobacterium is in that Lactobacillus are classified into two groups, one group which does homofermentation and the other group which does heterofermentation, respectively while Bifidobacterium does heterofermentation only. Important characteristics of Bifidobacterium breve K-110 of Korean-type lactic acid bacteria are in that it has an therapeutic effect of treating colon cancer, bladder cancer and ascites cancer (J. Microbiol. Biotechnol. 9(3), 368 (1999)) and a preventive effect of gastric ulcer by inhibiting the growth of Helicobacter pylori which is a causative agent of gastric ulcer, thus being capable of using for treating gastric diseases (J. Microbiol. Biotechnol. 10(4), 532 (2000)). Further, it was found that it improves an immunity by increasing production of the secretory antibody IgA, alleviates diarrhoea and constipation (Journal of the Korean Society for Food Science and Technology, 31(2), 547(1999)), and has an anti-mutagenesis effect against carcinogenic substance (Arch Pharm Res. 23(4), 482(2000)). In addition to, it was shown to have hepatoprotective effect against hepatotoxicity (Journal of the Korean Society for Food Science and Technology, 31(4), 1096(1999)). Generally, examples of the physiological activity of lactic acid bacteria include inhibition of the growth of harmful bacteria, alleviation of lactose intolerance, reduction of serum cholesterol, anti-cancer action, immunological action, relief of diarrhoea and constipation, vitamin synthesis, etc. Bifidobacteria begin to appear from about day 3 - 4 after one's birth, then grow to be the most dominant bacteria on about day 5 and existing E.coli or other lactic acid bacteria, Lactobacillus, Streptococcus, etc. decrease to one hundredth. This is believed due to a factor which is present only in breast milk and promotes the growth of the Bifidobacteria and thus we can see that among the intestinal flora Bifidobacteria are the most important bacteria, compared with the other lactic acid bacteria. The prior art is a generalized method comprising the steps of inoculating lactic acid bacteria into milk and adding powdered skim milk thereto to proliferate lactic acid bacteria so as to thereby prepare lactic acid beverage. Examples of patents for producing lactic acid beverage or lactic acid using cereals include a vegetable and herbal materials-derived lactic acid fermentation beverage (Korean Patent Publication Laid-Open No. 2000-0055832) and a rice sprout beverage (Korean Patent Publication Laid-Open No. 1998-0023072) using Lactobacillus plantarum, a process for preparing a lactic acid fermentation product using rice in the form of grains (Korean Patent Publication Laid-Open No. 1992-16030), a process for preparing a liquid lactic acid fermentation product using powdered cereals (Korean Patent Publication Laid-Open No. 1997-14592), a process for producing lactic acid using soybean-derived ingredients (Korean Patent Publication Laid-Open No. 2000-73826), etc. However, these methods comprise steps of mixing milk, or adding saccharides such as glucose, which is considerably different from the present method, and bacterial strain used therein is also different from the present invention using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria.
Disclosure of Invention The object of the present invention is to provide a method for preparing a fermentation product of soybean by using Korean-type lactic acid bacteria, said method comprising the steps of soaking soybean in water for 4 ~ 6 hours, adding water to said soaked soybean in a predetermined ratio, grinding them to obtain the ground materials of soybean, heating and allowing them to cool, inoculating said Bifidobacterium breve K-110 into them, and then fermenting them, when performing of a soybean fermentation using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria. Another object of the present invention is to provide a method for preparing a fermentation product of soybean comprising the steps of adding ascorbic acid to the ground materials of soybean in concentration of 0.025 ~ 0.2% and fermenting them to thereby promote the growth of the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria, when performing of a soybean fermentation using the Bifidobacterium breve K- 110 of Korean-type lactic acid bacteria. A further object of the present invention is to provide a method for preparing a powdered fermentation product of soybean having viable lactic acid bacteria, comprising the step of freeze-drying a fermentation product of soybean obtained by inoculating the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria into the ground materials of soybean and fermenting them for 12 ~ 48 hours. A further object of the present invention is to provide a method for preparing a fermentation product of germinated soybean, comprising the steps of adding ascorbic acid to ground materials of the germinated soybean and fermenting them with the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria. A further object of the present invention is to provide a method for enhancing content of γ -aminobutyric acid, one of the physiologically active substance and phytoestrogens comprising step of fermenting soybean and germinated soybean using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria.
Best mode for Carrying Out the Invention The following examples are provided to better elucidate the practice of the present invention. It will be readily apparent to those skilled in the art that various changes and modifications of an obvious nature may be made without departing from the spirit of the invention, and all such changes and modifications are considered to fall within the scope of the invention as defined by the appended claims.
EXAMPLES Example 1 : Determination of the ratio of water in performing of soybean fermentation using Korean-type lactic acid bacteria Commercially available soybean was soaked in water for 4 ~ 6 hours and water was drained. Said soaked soybean was mixed with water in a ratio of 1 :2(W/V), 1 :4(W/V)5 1:6(W/V) and 1:8(W/N), respectively. They were finely ground with a mixer or colloidal mill for 5 — 10 minutes to prepare ground materials of soybean. Said materials were heated and boiled in a double pot or heating vessel for further 5 minutes from when it reached a maximum temperature as shown in Table 1. The maximum temperature showed 60 ~ 75 °C although it was slightly different with a ratio of water.
Table 1. A maximum temperature with a mixing ratio of soybean to water, upon heating
Figure imgf000007_0001
The ground materials of soaked soybean, which were heated under the condition of temperature in Table 1 as above, were allowed to cool, and thereto was inoculated 1% of Bifidobacterium breve K-110 (bacterial number of 1.5 ~ 2.0 X 102 Iml) grown on TS medium for 24 hours. Then, they were fermented at 37°C for 24 hours and observed for a change in pH. The result measured was shown in Table 2. When performing of fermentation with a different ratio of water, there was no significant difference in the value of pH measured, but the pH value for a fermentation product of soaked soybean to water (1:4, W/V) was lowest with pH 4.2. However, in characters of the ground materials, if amount of water is excessively less, i.e. 1:2(W/N) of soybean to water ratio, compounded condition was very thick, with a result of difficulty in homogeneous fermentation. After the lowest pH value appeared at 1 :4 (W/N) of soaked soybean to water ratio, the pH value showed a tendency to rise gradually from a ratio of more than 1 :6. In other words, the pH value has showed 4.2±0.07 for 1:4 (WN) of soaked soybean to water ratio, 4.4±0.07 for 1:6 (W/N) of soaked soybean to water ratio and 4.6±0.21 for 1:8 (W/N) of soaked soybean to water ratio, respectively. The optimum addition ratio of water was 4 times as the weight of soaked soybean, when performing of fermentation using Korean-type lactic acid bacteria, based on the characters and pH values of the ground materials of soybean.
Table 2. Change in pH value after 24 h-fermentation with a mixing ratio of soybean and water
Figure imgf000008_0001
* represents soybean soaked in water for 4 hours. Example 2 : Determination of the addition amount of ascorbic acid in performing of soybean fermentation using Korean-type lactic acid bacteria
Water-soaked soybean was mixed with water in a ratio of 1:4(W/N) and then finely ground with a mixer or colloidal mill for 5 to 10 minutes to prepare ground materials. Said materials were heated and boiled in a double-pot or heating vessel for further 5 minutes from when it reached a maximum temperature of 75 "Cand then allowed to cool. Thereafter, to said materials was inoculated 1% of Bifidobacterium breve K-l 10 of Korean-type lactic acid bacteria (grown on TS medium for 24 hours). At that time, to examine the effect of ascorbic acid, there was added ascorbic acid with concentrations of 0%, 0.025%, 0.05%, 0.1% and 0.2%, respectively, prior to heating of said ground materials. After addition of ascorbic acid with the above concentrations and fermentation for 24 hours, the bacterial number was determined using pH and BL agar plate. Table 3 shows the result. The pH value prior to fermenting was the value of 6.6 ~ 5.7 which was decreased with increasing of the concentration of ascorbic acid, but the pH value after 24 h- fermenting was the value of 4.4 ~ 4.2 which was lowered by order of 2.4 ~ 1.4 compared with prior to fermenting, so it can be seen that lactic acid produced by fermentation process have induced reduction of pH value. After fermentation, the number of Bifidobacteria has showed 4.40 X 109 for the group to which 0% of ascorbic acid was added, 2.02 X 1012 for the group to which 0.025% of ascorbic acid was added, 9.21 X 10 for the group to which 0.05% of ascorbic acid was added, 2.34 X 108 for the group to which 0.1% of ascorbic acid was added and 1.01 X 108 for the group to which 0.2% of ascorbic acid was added, respectively. The number of Bifidobacteria increased until addition amount of ascorbic acid increased by 0.05%, while at concentration of ascorbic acid after 0.05% the number of Bifidobacteria rather showed a tendency to decrease. Thus, a suitable addition concentration of ascorbic acid was 0.05% at which the number of Bifidobacteria was maximum.
Table 3. pH value and the number of Bifidobacterium breve K-110 with concentration of ascorbic acid added, in soybean fermentation.
Figure imgf000009_0001
Example 3 : Determination of fermentation period Water-soaked soybean was mixed with water in a ratio of 1:4(W/N) and then finely ground with a mixer or colloidal mill for 5 ~ 10 minutes to prepare ground materials of soybean. 0.05% of ascorbic acid was added thereto, heated and boiled in a double pot or heating vessel for further 5 minutes from when it reached a maximum temperature of 75 °C and then allowed to cool. Thereafter, to said materials was inoculated 1% of Bifidobacterium breve K-110 of Korean-type lactic acid bacteria and they were fermented at 37 °C for 0, 2, 12, 24, 36 and 48 hours to obtain fermentation product of soybean. pH and the number of Bifidobacterium breve K-110 for said fermentation product were measured and the result was shown in Table 4. The number of lactic acid bacteria prior to fermenting was 0, but it was 4.65 X 104 for 2 h-fermenting, 5.70 X 1013 for 12 h- fermenting and 6.01 X 1014 for 24 h-fermenting with showing maximum number of bacteria, respectively. After that, the bacterial number was 4.18 X 1013 for 36 h- fermenting in which it was decreased, compared to 24 h-fermenting, and 4.13 X 10 for 48 h-fermenting with further decreasing. Therefore, the maximum number of bacteria can be obtained by 24 h-fermenting the ground materials of soybean using Bifidobacterium breve K-110 of Korean-type lactic acid bacteria.
Table 4. Determination of the number of lactic acid bacteria with fermentation period of ground soybean materials.
Figure imgf000010_0001
Example 4 : Number of lactic acid bacteria in freeze-drying fermentation product of soybean.
When 24 h-fermentation product of soybean which showed maximum number of lactic acid bacteria was frozen at a temperature of -20 to -30 °C and then freeze-dried for 24 hours, the number of viable lactic acid bacteria measured was 7.79 X 1012/g. Prior to freeze-drying by freezing, the number of lactic acid bacteria was 6.01 X 1014/g, while upon freeze-drying it was 7.79 X 1012/g, with a decrease of 102. Meanwhile, for using as preparations of lactic acid bacteria according to the Korean Food Code, bacterial number should be 108/g, while a fermentation product of soybean according to the present invention has 7.79 X 1012/g which is much larger than 108/g, thus being capable of using as preparations of lactic acid bacteria.
Example 5 : Preparation of fermentation product of the Korean-type lactic acid bacteria using germinated soybean
Water- soaked soybean for 4 h was germinated at a temperature of 25 ~ 30°C for 0, 12, 24 and 36 hours, respectively. Said germinated soybean was mixed with water in a ratio of 1:4(W/N) and then finely ground with a mixer or colloidal mill for 5 ~ 10 minutes to prepare ground materials of soybean. 0.05% of ascorbic acid was added thereto, heated and boiled in a double pot or heating vessel for further 5 minutes from when it reached a maximum temperature of 75 °C and then allowed to cool. Thereafter, to said materials was inoculated 1% of Bifidobacterium breve K-110 of Korean-type lactic acid bacteria (1.5 ~ 2.0 X 102/ β) and they were fermented at 37°C for 24 hours to obtain fermentation product of soybean. The pH and number of Bifidobacteria for said fermentation product were measured and the result was shown in Table 5. When fermenting for 24 hours using ungerminated (before germination) soybean, the number of lactic acid bacteria was 8.50 X 1014. When fermenting for 24 hours using 12 h-germinated soybean, the number of lactic acid bacteria was 1.00 X 1014 which was not significantly different from the case of using ungerminated soybean. However, the 1 number of lactic acid bacteria was 7.07 X 10 for the case of using 24 h-germinated soybean and 1.00 X 1012 for the case of using 36 h-germinated soybean, respectively, with resulting in decrease of bacterial number by using soybean having a long germination period. Thus, when using germinated soybean, it is preferred to use less than 12 h- germinated soybean.
Table 5. Changes in pH and the number of lactic acid bacteria for fermentation product using soybean having different germination period
Figure imgf000012_0001
Example 6 : Content of γ-aminobutyric acid in a fermentation product of soybean using Korean-type lactic acid bacteria
It was examined for a change in content of γ-aminobutyric acid contained in a fermentation product of soybean fermented according to procedures of Examples 3 and 5. The result showed from Table 6 that the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria increased a content of γ-aminobutyric acid. A content of γ- aminobutyric acid in soybean prior to fermenting was 20.85±0.70 mg%, but it was 54.50±3.54 mg% with an increase of about 2.6 times upon 24 h-fermenting with Korean- type lactic acid bacteria. The content of γ-aminobutyric acid was 89.66±5.97 mg% for 12 h-germinated soybean, but it was 133.24±13.05 mg% for fermenting of 12 h-germinated soybean by using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria, with an increase of about 1.5 times, compared to before fermenting. Thus, it was believed that the Bifidobacterium breve K-110 also had a function of synthesizing γ-aminobutyric acid. γ-aminobutyric acid (GAB A) is one of the neurotransmitters present in cerebrum, etc. and reported to have functions of improving cerebral blood flow and enhancing cerebral metabolism, thereby having effects in cerebral apoplexy, brain trauma and cerebral arterial sequela (Arch. Neurol. 37, 352 (1980)). Besides, due to having a hypotensive effect, it is one of the substances using for prevention of hypertension (Japan Society for Bioscience, Biotechnology, and Agrochemistry (JSBA), 61, 1449 (1987)). γ- aminobutyric acid, which is one of the neurotransmitters present in cerebrum, is used as preparations for intravenous injection for improving cerebral blood flow and enhancing cerebral metabolism in cerebral apoplexy, brain trauma and cerebral arterial sequela, and is commercially available as oral preparations in the form of tablet containing 5 ~ 10 mg of γ-aminobutyric acid in Japan (Journal of the Japanese Society for Food Science and Technology 46, 323 (1999)). It was examined for the improving effects of climacteric disorders and senile mental disorders using γ-aminobutyric acid and the result showed that when taking 26.5 mg of γ -aminobutyric acid/day, about 75% of the psychic diseases such as headache and depression or the climacteric disorders accompanying various symptoms were reported to be cured (Journal of the Japanese Society for Food Science and Technology 47, 596 (2000)). Thus, the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria which is capable of increasing content of γ -aminobutyric acid can be utilized as a new γ-aminobutyric acid-enriched food material or a functional food material.
Table 6. Change in content of γ-aminobutyric acid before and after fermenting of soybean using Bifidobacterium breve K-110
Figure imgf000014_0001
Example 7 : Increase in content of isoflavone, phvtoestrogen of soybean fermentation product by using the Korean-type lactic acid bacteria
It was examined for change in content of isoflavone contained in a fermentation product of soybean fermented according to procedures of Examples 3 and 5. The result showed from Table 7 that the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria increased content of phytoestrogens such as diadzein, glycitein and genistein. Further, content of isoflavonoids diadzin, glycitin and genistin decreased as a fermentation process progressed. In other words, during the course of fermentation using the Korean- type lactic acid bacteria, contents of diadzin, glycitin and genistin decreased, while contents of diadzein, glycitein and genistein having strong activity of phytoestrogen increased. Thus, it could be seen that diadzin, glycitin and genistin had been converted to diadzein, glycitein and genistein. Generally, isoflavonoids diadzin, glycitin and genistin which are present in soybean don't have effects like phytoestrogens by themselves, but it was reported that diadzein, glycitein and genistein in the form of aglycon in which sugar residues bound to diadzin, glycitin and genistin were removed, have function as phytoestrogens. Therefore, it could be seen that flavonoids (such as diadzin, glycitin and genistin) having no activity of phytoestrogens prior to fermenting were converted to the form of flavonoids(such as diadzein, glycitein and genistein) having strong activity of phytoestrogens, when fermenting of soybean using lactic acid bacteria. Prior to fermenting, contents of diadzein, glycitein and genistein in soybean were 5.38 mg/lOOg, 1.11 mg/lOOg and 9.91 mg/lOOg, respectively, but when 24 h-fermenting using the Korean-type lactic acid bacteria, they were 25.06 mg/lOOg, 3.70 mg/lOOg and 52.41 mg/lOOg with an increasing rate of 4.66, 3.33 and 5.23 times, respectively. Meanwhile, when fermenting 12 h-germinated soybean for 24 hours by using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria, contents of diadzein, glycitein and genistein were 19.89 mg/lOOg, 3.40 mg/lOOg and 41.36 mg/lOOg with an increasing rate of 3.97, 3.06 and 4.17 times, respectively, compared to before germinating of soybean. Thus, the Bifidobacterium breve K-110 was considered to have a function of synthesizing phytoestrogens as well. Because phytoestrogens diadzein, glycitein and genistein have an action to increase a metabolism of carcinogenic substances in cell cultivation experiment, it was reported that they have the effects to prevent breast cancer and prostate cancer and also various kinds of cancers such as gastric cancer, colon cancer, etc. (The Korean Society for the Research of Soybean, Academic Publication 2001), and serve to reduce a risk of cardiovascular diseases and cancers (The Food Industry, Nov. 1998). They say that these phytoestrogens diadzein, glycitein and genistein have an anti- oxidative effect, and among them an anti-oxidative effect of glycitein is greatest (The Korean Society for the Research of Soybean, 14:91 (1997)). Further, genistein is reported to block the growth of tumor (The Korean Society for the Research of Soybean, 14:91 (1997)), and it inhibits the lipid oxidation caused by lipid peroxides (J. Nutr. Biochem., 6:481(1995)). Meanwhile, They say that in countries of East Asia such as Korea, China and Japan, taking a large amount of soybean in one's diet, the reason why the mortality caused by breast cancer or prostate cancer is lower than in U.S.A. is due to the actions of various ingredients including phytoestrogen substances and also soybean peptide, etc. contained in soybean (The Korean Society for the Research of Soybean, 14:91 (1997)). Thus, it is important to have a technology for preparing soybean products containing a large amount of phytoestrogen substances. Therefore, the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria, capable of enhancing the contents of phytoestrogens diadzein, glycitein and genistein, can be used as a new phytoestrogens-enriched food material or a functional food material.
Table 7. Changes in contents of phytoestrogens diadzein, glycitein and genistein before and after fermenting of soybean using the Bifidobacterium breve K-110 (unit: mg/lOOg)
Figure imgf000016_0001
Industrial Applicability As above-mentioned, based on said technical constitution, the the present invention can provide a lactic acid bacteria-fermentation product of soybean using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria. The fermentation products of soybean and germinated soybean containing more than 108 of the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria obtained according to the present invention can be used as preparations of lactic acid bacteria, as well as materials for various functional foods such as materials for health food and materials for eating uncooked food and specified raw food due to high contents of the γ- aminobutyric acid, one of the physiologically active substances and the diadzein, glycitein and genistein functioning as phytoestrogens.

Claims

What Is Claimed Is:
1. A method for preparing a fermentation product of soybean using the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria, said method comprising steps of soaking soybean in water for 4 - 6 hours; admixing said soaked soybean with water in a ratio of 1 :2 ~ 1 :8(WN); grinding them with a mixer or mill to obtain the ground materials of soybean; heating said ground materials of soybean to a temperature of 60 °C ~ 75 °C and allowing them to cool; and inoculating the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria into them and fermenting them at 37 °C for 12 ~ 48 hours.
2. The method for preparing a fermentation product of soybean according to claim
1 , wherein ascorbic acid is added to said ground materials of soybean in concentration of 0.025 ~ 0.2%.
3. The method for preparing a fermentation product of soybean according to claim 1 or claim 2, further comprising steps of freezing said fermentation product of soybean which was inoculated and fermented with the Bifidobacterium breve K-110 of Korean- type lactic acid bacteria at a temperature of -20 °C to -30°C and freeze-drying them for 24 hours.
4. A method for preparing a fermentation product of soybean using the
Bifidobacterium breve K-110 of Korean-type lactic acid bacteria, said method comprising steps of germinating 4 ~ 6 h water-soaked soybean at a temperature of 20 °C ~ 30°C for 12 ~ 36 hours; admixing said germinated soybean with water in a ratio of 1:2 ~ 1:8(W/V); grinding them with a mixer or mill to obtain the ground materials of soybean; adding ascorbic acid to said ground materials of soybean in concentration of 0.05%, heating ground materials of soybean to a temperature of 60 °C ~ 75 °C and allowing them to cool; and inoculating the Bifidobacterium breve K-110 of Korean-type lactic acid bacteria into them and fermenting them at 37°C for 12 ~ 48 hours.
5. A method for enhancing the contents of γ-aminobutyric acid and phytoestrogens diadzein, glycitein and genistein, comprising step of fermenting 4 ~ 6 h water-soaked soybean or 12 ~ 36 h germinated soybean at a temperature of 25 °C ~ 30°C for 24 hours.
6. A food material having enriched γ-aminobutyric acid and phytoestrogens produced according to the method as claimed in claim 5.
PCT/KR2003/002156 2003-10-16 2003-10-16 A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria Ceased WO2005038008A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PCT/KR2003/002156 WO2005038008A1 (en) 2003-10-16 2003-10-16 A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria
AU2003273069A AU2003273069A1 (en) 2003-10-16 2003-10-16 A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/KR2003/002156 WO2005038008A1 (en) 2003-10-16 2003-10-16 A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria

Publications (1)

Publication Number Publication Date
WO2005038008A1 true WO2005038008A1 (en) 2005-04-28

Family

ID=34464673

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2003/002156 Ceased WO2005038008A1 (en) 2003-10-16 2003-10-16 A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria

Country Status (2)

Country Link
AU (1) AU2003273069A1 (en)
WO (1) WO2005038008A1 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2078461A4 (en) * 2006-10-31 2010-04-14 Fuji Oil Co Ltd FOOD OR BEVERAGE CONTAINING HIGHLY UNSATURATED FATTY ACIDS AND METHOD FOR THE PRODUCTION THEREOF
WO2013107913A1 (en) * 2012-01-19 2013-07-25 University College Cork - National University Of Ireland, Cork Gaba-producing culturable bacteria derived from the human gastrointestinal tract

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107410508A (en) * 2017-05-05 2017-12-01 扬州大学 A kind of production method of the fermented soybean milk rich in gamma aminobutyric acid

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR840003790A (en) * 1983-03-18 1984-10-04 정재원 How to improve the quality and yield of soymilk
EP0855140A1 (en) * 1997-01-22 1998-07-29 Fuji Oil Company, Limited Process for preparing a fermented soybean milk
KR19980076911A (en) * 1997-04-15 1998-11-16 김동현 New Korean Lactic Acid Bacteria and Their Uses Inhibit Intestinal Hazardous Enzyme Activity
WO1999011755A1 (en) * 1997-09-04 1999-03-11 Kabushiki Kaisha Yakult Honsha Bifidobacterium breve and fermented soy-milk prepared with the same
JP2000014356A (en) * 1998-04-27 2000-01-18 Yakult Honsha Co Ltd Manufacturing method of GABA-containing food and drink
JP2001120179A (en) * 1999-10-26 2001-05-08 Yakult Honsha Co Ltd Method for producing GABA-containing fermented milk
KR20010074615A (en) * 2001-06-28 2001-08-04 오석흥 Germinated grain foods with enhanced GABA (gamma-aminobutyric acid) contents and methods for the production of the foods
KR20030089176A (en) * 2002-05-17 2003-11-21 주식회사 바름인 Preparation of fermented soybean product enriched γ-aminobutylic acid and phytoestrogens using Bifidobacterium breve K-110 of korean-type lactic acid bacteria

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR840003790A (en) * 1983-03-18 1984-10-04 정재원 How to improve the quality and yield of soymilk
EP0855140A1 (en) * 1997-01-22 1998-07-29 Fuji Oil Company, Limited Process for preparing a fermented soybean milk
KR19980076911A (en) * 1997-04-15 1998-11-16 김동현 New Korean Lactic Acid Bacteria and Their Uses Inhibit Intestinal Hazardous Enzyme Activity
WO1999011755A1 (en) * 1997-09-04 1999-03-11 Kabushiki Kaisha Yakult Honsha Bifidobacterium breve and fermented soy-milk prepared with the same
JP2000014356A (en) * 1998-04-27 2000-01-18 Yakult Honsha Co Ltd Manufacturing method of GABA-containing food and drink
JP2001120179A (en) * 1999-10-26 2001-05-08 Yakult Honsha Co Ltd Method for producing GABA-containing fermented milk
KR20010074615A (en) * 2001-06-28 2001-08-04 오석흥 Germinated grain foods with enhanced GABA (gamma-aminobutyric acid) contents and methods for the production of the foods
KR20030089176A (en) * 2002-05-17 2003-11-21 주식회사 바름인 Preparation of fermented soybean product enriched γ-aminobutylic acid and phytoestrogens using Bifidobacterium breve K-110 of korean-type lactic acid bacteria

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2078461A4 (en) * 2006-10-31 2010-04-14 Fuji Oil Co Ltd FOOD OR BEVERAGE CONTAINING HIGHLY UNSATURATED FATTY ACIDS AND METHOD FOR THE PRODUCTION THEREOF
WO2013107913A1 (en) * 2012-01-19 2013-07-25 University College Cork - National University Of Ireland, Cork Gaba-producing culturable bacteria derived from the human gastrointestinal tract

Also Published As

Publication number Publication date
AU2003273069A1 (en) 2005-05-05

Similar Documents

Publication Publication Date Title
CN1559300A (en) A kind of preparation method of rice milk beverage
CN101014249A (en) Product which is fermented without lactose from a shake comprising non-vegetable dried fruits and/or orgeat
KR101697107B1 (en) Method for Preparing of Beverage Fermented by Lactic Acid Bacteria using Grain Syrup and Beverage Fermented by Lactic Acid Bacteria thereof
CN107593907A (en) A kind of processing method rich in resveratrol and gamma aminobutyric acid Yoghourt
CN106942549A (en) A kind of preparation method of full rice bud fermented beverage
KR101183963B1 (en) Manufacturing method of grain-free traditional rice punch
KR101461116B1 (en) The method for manufacturing Makgeolli kit with GABA producing lactic acid bacteria
CN110800899A (en) High-fiber hawthorn vinegar beverage and preparation method thereof
KR20130079173A (en) Fermented soymilk beverage composition using phaseolus angularis and rhynchosia nulubilis and the method thereof
KR102685690B1 (en) A process for the preparation of sikhye containing lactobacillus and the sikhye containing lactobacillus prepared therefrom
CN113693205A (en) Healthy flavored soybean milk formula and production process thereof
CN103976021A (en) Preparation method of nut functional yogurt
CN111567622A (en) Method for preparing yoghourt by compounding rice protein and rice starch
KR100451631B1 (en) Preparation of fermented soybean product enriched γ-aminobutylic acid and phytoestrogens using Bifidobacterium breve K-110 of korean-type lactic acid bacteria
KR100724059B1 (en) Lactic Acid Bacteria Fermentation of Mixed Grains and Its Manufacturing Method
WO2005038008A1 (en) A method for preparing a fermentation product of soybean having enriched #-aminobutyric acid and phytoestrogens using the bifidobacterium breve k-110 of korean-type lactic acid bacteria
CN108402252A (en) A kind of Schisandra chinensis multiple elements design tea beverage
KR20120116127A (en) Manufacture method of sikhye makgeolli and sikhye makgeolli
KR100303216B1 (en) Method for manufacturing lactic acid fermented beverages using mixed grains
KR101403593B1 (en) Yogurt comprising barley and preparation method thereof
CN109588493A (en) A kind of Soybean yogurt purple potato drink and preparation method thereof
KR20110122582A (en) Composition for weight control and immunological enhancement using vegetable liquid fermentation as an active ingredient
KR101234855B1 (en) Food composition using Chinese dioscorea and manufacturing method thereof
CN113273609A (en) Sugar-free lactobacillus beverage and preparation method thereof
CN118044624B (en) Composition containing dietary fiber and preparation method thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EPC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP